Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-09-22
1993-06-08
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
530402, 530409, 530410, 530380, 930280, 424 9, A61K 4902, A61K 4300
Patent
active
052177050
ABSTRACT:
A fibrin-binding protein such as t-PA is labeled with a detectable substance, such as a radionuclide, and administered to a patient for diagnosis of blood clots and for monitoring the dissolution thereof during therapy. The detectable substance preferably is attached to t-PA through linkers which specifically bind to the portion of the t-PA protein responsible for enzymatic activity, thereby diminishing this activity while leaving the fibrin-binding property of the protein intact.
REFERENCES:
patent: 4318904 (1982-03-01), Shaw et al.
patent: 4381346 (1983-04-01), Huasin et al.
patent: 4416865 (1983-11-01), Rhodes et al.
patent: 4418052 (1983-11-01), Wong
patent: 4425319 (1984-01-01), Yokoyama et al.
patent: 4427646 (1984-01-01), Olexa et al.
patent: 4663146 (1987-05-01), Morser et al.
patent: 4741900 (1988-05-01), Alvarez et al.
patent: 4741903 (1988-05-01), Smith
patent: 4913891 (1990-04-01), Fowler et al.
Baker et al., European Journal of Nuclear Medicine (1985) 10:155-159.
Kettner and Shaw, Thrombosis Research 14; 969-973.
Kettner and Shaw, Methods in Enzymology, vol. 80, [63] 826-842.
Kettner and Shaw, Biochemistry, vol. 17, No. 22, 1978.
Collen et al., Leuven, Belgium, and Upton, N.Y., "In Vivo Studies of a Synthetic Inhibitor of Thrombin", J. Lab. Clin. Med., Jan. 1982.
Hnatowich et al., Eur. J. Nucl. Med. (1987) 13:467-473, "Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi".
International Search Report in the International (PCT) patent application that corresponds to U.S. Ser. No. 07/247.973.
Hadley Stephen W.
Mohler Marjorie A.
Reno John M.
Covert John M.
NeoRx Corporation
Stoll Robert L.
LandOfFree
Method of diagnosing blood clots using fibrin-binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing blood clots using fibrin-binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing blood clots using fibrin-binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1932188